Abstract

Objectives: Orthopedics and dentistry have widely utilized titanium alloys as biomaterials for dental implants, but limited research has been conducted on the fabrication of ceramic particle-reinforced Ti composites for further weight reductions. The current study compared titanium–titanium diboride metal composites (Ti-TiB2) with pure titanium (processed by powder metallurgy) in terms of toxicity, corrosion resistance, and wettability. Methods: First, cell lines of a primary dermal fibroblast normal human adult (HDFa) were used to test the cytocompatibility (in vitro) of the composite and pure Ti using an indirect contact approach. Corrosion testing was performed for the materials using electrochemical techniques such as potentiodynamic polarization in a simulated bodily fluid (SBF) in conjunction with a three-electrode electrochemical cell. The entire set of experimental tests was conducted according to the ASTM F746-04 protocol. The contact angles were measured during wettability testing in accordance with ASTM D7334-08. An X-ray diffractometer (XRD) was used to catalog every phase that was visible in the microstructure. A scanning electron microscope (SEM) and energy-dispersive X-ray spectroscopy (EDS) were used to determine the chemical composition. Results: The cytotoxicity tests revealed that there was no detectable level of toxicity, and there was no significant difference in the impact of either of the two materials on the viability of human fibroblasts. An increase in the corrosion resistance of the composite (0.036 ± 0.0001 mpy (millimeters per year)) demonstrated the development of a passive oxide coating. According to the findings, the composites showed a greater degree of hydrophilicity (contact angle 44.29° ± 0.28) than did the pure titanium (56.31° ± 0.47). Conclusions/Significance: The Ti-TiB2 composite showed no toxicity and better corrosion resistance and wettability than did pure Ti. The composite could be a suitable alternative to Ti for applications involving dental implants.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call